<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="bmc70119" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomed Chromatogr</journal-id><journal-id journal-id-type="iso-abbrev">Biomed Chromatogr</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1099-0801</journal-id><journal-id journal-id-type="publisher-id">BMC</journal-id><journal-title-group><journal-title>Biomedical Chromatography</journal-title></journal-title-group><issn pub-type="ppub">0269-3879</issn><issn pub-type="epub">1099-0801</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40404565</article-id><article-id pub-id-type="pmc">PMC12097965</article-id>
<article-id pub-id-type="doi">10.1002/bmc.70119</article-id><article-id pub-id-type="publisher-id">BMC70119</article-id><article-id pub-id-type="other">6140171</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Determination of 25&#x02010;Hydroxyvitamin D<sub>3</sub> in Rat Brain by Derivatization&#x02010;Assisted LC/ESI&#x02010;MS/MS</article-title></title-group><contrib-group><contrib id="bmc70119-cr-0001" contrib-type="author"><name><surname>Shibuya</surname><given-names>Toma</given-names></name><xref rid="bmc70119-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="bmc70119-cr-0002" contrib-type="author"><name><surname>Shishikura</surname><given-names>Fuwari</given-names></name><xref rid="bmc70119-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="bmc70119-cr-0003" contrib-type="author"><name><surname>Yoshida</surname><given-names>Natsuki</given-names></name><xref rid="bmc70119-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="bmc70119-cr-0004" contrib-type="author"><name><surname>Ogawa</surname><given-names>Shoujiro</given-names></name><xref rid="bmc70119-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="bmc70119-cr-0005" contrib-type="author" corresp="yes"><name><surname>Higashi</surname><given-names>Tatsuya</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7890-6262</contrib-id><xref rid="bmc70119-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>higashi@rs.tus.ac.jp</email></address></contrib></contrib-group><aff id="bmc70119-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Faculty of Pharmaceutical Sciences</named-content>
<institution>Tokyo University of Science</institution>
<city>Tokyo</city>
<country country="JP">Japan</country>
</aff><aff id="bmc70119-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Faculty of Pharmacy and Pharmaceutical Sciences</named-content>
<institution>Fukuyama University</institution>
<city>Fukuyama</city>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Tatsuya Higashi (<email>higashi@rs.tus.ac.jp</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2025</year></pub-date><volume>39</volume><issue seq="130">7</issue><issue-id pub-id-type="doi">10.1002/bmc.v39.7</issue-id><elocation-id>e70119</elocation-id><history>
<date date-type="rev-recd"><day>12</day><month>5</month><year>2025</year></date>
<date date-type="received"><day>14</day><month>4</month><year>2025</year></date>
<date date-type="accepted"><day>13</day><month>5</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons, Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Biomedical Chromatography</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:BMC-39-e70119.pdf"/><abstract><title>ABSTRACT</title><p>Recent studies have suggested that vitamin D deficiency may have relations with various neuropsychiatric diseases as well as bone diseases. However, the concentrations of vitamin D metabolites in the brain and the relationship between their brain and serum concentrations remain poorly understood. To answer these questions, we developed and validated an LC/ESI&#x02010;MS/MS method for quantifying 25&#x02010;hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>], an established marker for assessing vitamin D sufficiency/deficiency, in the rat brain and compared the brain concentrations with the serum concentrations. To enhance the assay sensitivity and specificity, the 25(OH)D<sub>3</sub> was derivatized with 4&#x02010;[4&#x02010;(1&#x02010;pipelidinyl)phenyl]&#x02010;1,2,4&#x02010;triazoline&#x02010;3,5&#x02010;dione (PIPTAD) after purification of the brain sample by a two&#x02010;step solid&#x02010;phase extraction. A good linearity was obtained within the range of 20&#x02013;1000&#x02009;pg/g tissue, and the intra&#x02010;assay and interassay precision and accuracy were acceptable. In normal rats (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6), the brain 25(OH)D<sub>3</sub> concentrations ranged from 128 to 175&#x02009;pg/g tissue, which were extremely low (approximately 1/100) compared to the serum concentrations. The bile duct ligation caused the decreased serum 25(OH)D<sub>3</sub> level, which produced the subsequent decreased brain 25(OH)D<sub>3</sub> level (44&#x02013;79&#x02009;pg/g, <italic toggle="yes">n</italic>&#x02009;=&#x02009;6). These results strongly suggested that the serum 25(OH)D<sub>3</sub> concentration has a significant effect on its brain level.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="bmc70119-kwd-0001">25&#x02010;hydroxyvitamin D<sub>3</sub>
</kwd><kwd id="bmc70119-kwd-0002">derivatization</kwd><kwd id="bmc70119-kwd-0003">LC/ESI&#x02010;MS/MS</kwd><kwd id="bmc70119-kwd-0004">rat brain</kwd><kwd id="bmc70119-kwd-0005">serum</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Japan Society for the Promotion of Science
</institution><institution-id institution-id-type="doi">10.13039/501100001691</institution-id></institution-wrap></funding-source><award-id>23K06070</award-id></award-group></funding-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="8"/><word-count count="6100"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:22.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="bmc70119-ntgp-0001"><fn fn-type="funding" id="bmc70119-note-0001"><p>
<bold>Funding:</bold> This work was supported by the Japan Society for the Promotion of Science (23K06070).</p></fn></fn-group></notes></front><body id="bmc70119-body-0001"><sec id="bmc70119-sec-0001"><label>1</label><title>Introduction</title><p>Vitamin D<sub>3</sub>, a major form of vitamin D in humans, is synthesized from 7&#x02010;dehydrocholesterol in the skin by the ultraviolet (UV) photochemical reaction followed by thermal isomerization as well as it is directly absorbed from one's diet. Vitamin D<sub>2</sub>, another form of vitamin D, is derived only from the diet, especially from vitamin D<sub>2</sub>&#x02010;containing supplements and sun&#x02010;dried mushrooms, and therefore, vitamin D<sub>2</sub> and its metabolites are detected only in individuals taking these foods (Miyamoto et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0020" ref-type="bibr">2023</xref>). Vitamin D<sub>3</sub> is first converted to 25&#x02010;hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>], the circulating form, in the liver by vitamin D 25&#x02010;hydroxylase (Tuckey et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0031" ref-type="bibr">2019</xref>). The circulating level of vitamin D<sub>3</sub> is much lower than that of 25(OH)D<sub>3</sub> (Hu et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0013" ref-type="bibr">2020</xref>). 25(OH)D<sub>3</sub> is then converted to 1&#x003b1;,25&#x02010;dihydroxyvitamin D<sub>3</sub> [1,25(OH)<sub>2</sub>D<sub>3</sub>], which is the ligand for the vitamin D receptor (VDR), in the kidney by 25&#x02010;hydroxyvitamin D 1&#x003b1;&#x02010;hydroxylase (CYP27B1) to exert various biological activities including bone formation. Recent studies have suggested that vitamin D deficiency, which is diagnosed based on the decreased circulating 25(OH)D<sub>3</sub> levels, may have relations with neuropsychiatric diseases including Alzheimer's disease, Parkinson's disease, schizophrenia, depression, and autism (Eyles et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0005" ref-type="bibr">2013</xref>; Rihal et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0025" ref-type="bibr">2022</xref>; Wassif et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0032" ref-type="bibr">2023</xref>), as well as well&#x02010;known bone diseases. However, at present, the concentrations of vitamin D<sub>3</sub> metabolites in the brain and the relationship between their brain and serum concentrations remain poorly understood.</p><p>As the brain is encased in the skull, it is a good theory that the UV exposure&#x02010;based synthesis of vitamin D<sub>3</sub> does not occur in the brain. The circulating concentration of 25(OH)D<sub>3</sub> (<italic toggle="yes">ca.</italic> 40&#x02013;100&#x02009;nM) is nearly thousand&#x02010;fold higher than that of 1,25(OH)<sub>2</sub>D<sub>3</sub> (<italic toggle="yes">ca.</italic> 40&#x02013;150 pM) in humans (Higashi et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0010" ref-type="bibr">2010</xref>; Tuckey et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0031" ref-type="bibr">2019</xref>), and 25(OH)D<sub>3</sub> also has a significantly longer half&#x02010;life than 1,25(OH)<sub>2</sub>D<sub>3</sub> (2&#x02013;3&#x02009;weeks and 4&#x02013;6&#x02009;h, respectively) (Holick&#x000a0;<xref rid="bmc70119-bib-0012" ref-type="bibr">2009</xref>). CYP27B1 and VDR are widely expressed in the brain (Eyles et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0006" ref-type="bibr">2005</xref>; Harms et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0008" ref-type="bibr">2011</xref>). When taken these observations together, a plausible theory is that the serum 25(OH)D<sub>3</sub> migrates to the brain, then is converted to 1,25(OH)<sub>2</sub>D<sub>3</sub> in a particular location of the brain to exert the effects on the brain function <italic toggle="yes">via</italic> VDR. Given this perspective, the comparison of the brain and serum 25(OH)D<sub>3</sub> concentrations of the same individual might potentially provide an insight into understanding the relationships between neuropsychiatric diseases and the vitamin D status (sufficiency/deficiency).</p><p>Some studies demonstrated that 25(OH)D<sub>3</sub> was present in the rat (Xue et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0033" ref-type="bibr">2015</xref>) and mouse (Ahonen et&#x000a0;al. <xref rid="bmc70119-bib-0001" ref-type="bibr">2014</xref>; Stephenson et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0028" ref-type="bibr">2023</xref>) brain tissues at quantifiable concentrations by liquid chromatography/tandem mass spectrometry (LC/MS/MS). 25(OH)D<sub>3</sub> was also detected in a postmortem human brain sample (Fu et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0007" ref-type="bibr">2019</xref>). Xue et&#x000a0;al.&#x000a0;(<xref rid="bmc70119-bib-0033" ref-type="bibr">2015</xref>) developed a method for quantifying 25(OH)D<sub>3</sub> in the brain and serum of rats fed with different doses of vitamin D<sub>3</sub> by LC/electrospray ionization (ESI)&#x02010;MS/MS combined with derivatization using 4&#x02010;phenyl&#x02010;1,2,4&#x02010;triazoline&#x02010;3,5&#x02010;dione (PTAD), a representative Cookson&#x02010;type reagent. With the aid of the derivatization, a clear peak derived from 25(OH)D<sub>3</sub> was observed in the selected reaction monitoring (SRM) chromatogram of the brain sample; meanwhile, the nonderivatization method gave a peak with a low signal&#x02010;to&#x02010;noise ratio (S/N), which might be insufficient for identifying the peak as that derived from true 25(OH)D<sub>3</sub> (Ahonen et&#x000a0;al. <xref rid="bmc70119-bib-0001" ref-type="bibr">2014</xref>; Stephenson et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0028" ref-type="bibr">2023</xref>). Because the brain tissue is rich in oxysterols (Karu et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0017" ref-type="bibr">2011</xref>; Meljon et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0019" ref-type="bibr">2013</xref>) and some of which have the same molecular weights and similar physicochemical properties as 25(OH)D<sub>3</sub>, these oxysterols might interfere with the measurement of 25(OH)D<sub>3</sub> in the brain tissue. We have demonstrated that derivatization is an effective approach to enhance the sensitivity and specificity for the LC&#x02010;ESI&#x02010;MS/MS quantification of lipophilic bioactive compounds in the brain (Higashi et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0011" ref-type="bibr">2024</xref>; Nishimoto&#x02010;Kusunose et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0022" ref-type="bibr">2023</xref>; Shibuya et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0026" ref-type="bibr">2024</xref>). Furthermore, we have developed several Cookson&#x02010;type reagents including 4&#x02010;(4&#x02010;dimethylaminophenyl)&#x02010;1,2,4&#x02010;triazoline&#x02010;3,5&#x02010;dione (DAPTAD) (Ogawa, Ooki, et&#x000a0;al. <xref rid="bmc70119-bib-0023" ref-type="bibr">2013</xref>) and 4&#x02010;[4&#x02010;(1&#x02010;pipelidinyl)phenyl]&#x02010;1,2,4&#x02010;triazoline&#x02010;3,5&#x02010;dione (PIPTAD, Figure&#x000a0;<xref rid="bmc70119-fig-0001" ref-type="fig">1</xref>) (Takada et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0029" ref-type="bibr">2023</xref>). Among them, the derivatives with PIPTAD showed a stronger retention on the reversed&#x02010;phase LC than the derivative with other Cookson&#x02010;type reagents, which had a great advantage in separation from any interfering substances, as well as a high ESI&#x02010;MS/MS detectability (Takada et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0029" ref-type="bibr">2023</xref>). Due to these characteristics, PIPTAD was expected to work well for the analysis of 25(OH)D<sub>3</sub> in the brain.</p><fig position="float" fig-type="FIGURE" id="bmc70119-fig-0001"><label>FIGURE 1</label><caption><p>Derivatization reaction scheme of 25(OH)D<sub>3</sub> with PIPTAD and structure of product ion from the derivative.</p></caption><graphic xlink:href="BMC-39-e70119-g003" position="anchor" id="jats-graphic-1"/></fig><p>Xue et&#x000a0;al.&#x000a0;(<xref rid="bmc70119-bib-0033" ref-type="bibr">2015</xref>) revealed that there was a strong positive correlation between the brain and serum 25(OH)D<sub>3</sub> concentrations in rats fed with a greater&#x02010;than&#x02010;usual amount of vitamin D<sub>3</sub>, and the serum levels were always remarkably higher than the brain levels. This was a critical report demonstrating that the serum 25(OH)D<sub>3</sub> concentration has a significant effect on its brain level. However, it is not yet known whether these results can be reproduced in the rats fed with a usual diet or in vitamin D deficiency&#x02010;model rats. As there has been an interest in the relationships between neuropsychiatric diseases and the vitamin D deficiency, a study using a vitamin D deficiency&#x02010;model rat becomes even more important. In the vitamin D deficiency&#x02010;model rat, the brain 25(OH)D<sub>3</sub> is expected to be at less than ng/g tissue levels; therefore, an LC/ESI&#x02010;MS/MS method with an enhanced sensitivity and specificity is needed for reliably determining the brain 25(OH)D<sub>3</sub> concentrations.</p><p>Based on this background information, the first objective of this study was to develop and validate a method for quantifying 25(OH)D<sub>3</sub> in rat brain by the PIPTAD derivatization followed by LC/ESI&#x02010;MS/MS. The second one was the determination of the brain 25(OH)D<sub>3</sub> concentrations in normal, fasted and bile duct&#x02010;ligated (BDL) rats to discuss the effect of the circulating (serum) 25(OH)D<sub>3</sub> concentration on the brain 25(OH)D<sub>3</sub> concentration.</p></sec><sec id="bmc70119-sec-0002"><label>2</label><title>Experimental</title><sec id="bmc70119-sec-0003"><label>2.1</label><title>Chemicals, Reagents, and Materials</title><p>25(OH)D<sub>3</sub> and [6,19,19&#x02010;<sup>2</sup>H<sub>3</sub>]&#x02010;25(OH)D<sub>3</sub> [internal standard (IS)] were purchased from the FUJIFILM Wako Pure Chemical Corporation (Osaka, Japan) and IsoSciences (King of Prussia, PA, USA), respectively. The concentrations of the 25(OH)D<sub>3</sub> working solutions (in ethanol) were 100, 200, 500, 1000, 2000, 5000 and 10,000&#x02009;pg/mL. The IS working solution (in ethanol) with the concentration of 1000&#x02009;pg/mL was also prepared. 3&#x02010;<italic toggle="yes">Epi</italic>&#x02010;25&#x02010;hydroxyvitamin D<sub>3</sub> [3&#x02010;<italic toggle="yes">epi</italic>&#x02010;25(OH)D<sub>3</sub>] was purchased from the Cayman Chemical Company (Ann Arbor, MI, USA). 7&#x003b1;&#x02010;Hydroxycholestenone (Ogawa, Zhou, et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0024" ref-type="bibr">2013</xref>) and 4&#x003b2;&#x02010;hydroxy&#x02010;7&#x02010;dehydrocholesterol [4&#x003b2;(OH)&#x02010;7&#x02010;DHC] (Kawamoto et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0018" ref-type="bibr">2013</xref>) were gifts from Professor Takashi Iida (Nihon University, Tokyo). PIPTAD was synthesized in our laboratory by a known method (Takada et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0029" ref-type="bibr">2023</xref>). The LC/MS grade methanol and ammonium formate were purchased from the FUJIFILM Wako Pure Chemical Corporation and used for the mobile phase. A Puric&#x02010;&#x003b1; system (Organo, Tokyo) was used to prepare ultrapure water for the mobile phase. All other reagents and solvents were of analytical grade from the Tokyo Chemical Industry (Tokyo, Japan). A Strata&#x02010;X cartridge (60&#x02009;mg adsorbent; Phenomenex, Torrance, CA, USA) was used immediately after successive flushing with ethyl acetate (1&#x02009;mL), methanol (1&#x02009;mL), and water (1&#x02009;mL). An InertSep SI cartridge (500&#x02009;mg adsorbent; GL Sciences, Tokyo) was used immediately after successive flushing with chloroform&#x02010;methanol (30:1, v/v, 4&#x02009;mL) and chloroform (4&#x02009;mL).</p></sec><sec id="bmc70119-sec-0004"><label>2.2</label><title>LC/ESI&#x02010;MS/MS</title><p>An LC/ESI&#x02010;MS/MS system comprised of a Shimadzu LC&#x02010;40D XS chromatograph and a Shimadzu LCMS&#x02010;8045 triple quadrupole mass spectrometer (Kyoto, Japan) was used in the positive&#x02010;ion mode. A Shimadzu SIL&#x02010;40C XS autosampler, DGU&#x02010;405 degasser, CTO&#x02010;40C column oven, and FCV&#x02010;20AH<sub>2</sub> diversion valve were also parts of this system. Methanol&#x02010;10&#x02009;mM of ammonium formate (4:1, v/v, isocratic mode) was used as the mobile phase and run through the Ascentis Express 90&#x02009;&#x000c5; C18 column (2.0&#x02009;&#x003bc;m, 100&#x02009;&#x000d7;&#x02009;2.1&#x02009;mm i.d.; Sigma&#x02010;Aldrich Japan, Tokyo) at the rate of 0.3&#x02009;mL/min and the temperature of 40&#x000b0;C. The SRM was used for the quantification. The MS/MS conditions were as follows: interface voltage, 4.0&#x02009;kV; Q1 prerod bias voltage, &#x02212;20&#x02009;V; Q3 prerod bias voltage, &#x02212;26&#x02009;V; collision energy, &#x02212;31&#x02009;eV; detector voltage, 1.76&#x02009;kV; nebulizer gas (N<sub>2</sub>) flow rate, 3&#x02009;L/min; drying gas (N<sub>2</sub>) flow rate, 5&#x02009;L/min; desolvation line temperature, 250&#x000b0;C; heat block temperature, 400&#x000b0;C; and collision gas (Ar), 230&#x02009;kPa. The SRM transitions were as follows: 25(OH)D<sub>3</sub>; <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 659.6&#x02009;&#x02192;&#x02009;381.3 and IS; <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 662.6&#x02009;&#x02192;&#x02009;384.3. LabSolutions software (version 5.118, Shimadzu) was used for the system control and data processing.</p></sec><sec id="bmc70119-sec-0005"><label>2.3</label><title>Collection of Brain and Serum Samples</title><p>All the rats (Wistar strain, male, 8&#x02009;weeks old) were obtained from the Sankyo Labo Service Corporation (Tokyo). The normal and BDL rats were fed a conventional diet and filtered tap water ad&#x000a0;libitum, whereas the fasted rats were given only water 24&#x02009;h before the experiment. This diet contained vitamin D<sub>3</sub> (2000&#x02009;IU/kg) and no vitamin D<sub>2</sub>. The BDL rats were used 7&#x02009;days after a common bile duct ligation operation (at 7&#x02009;weeks old). BDL rat is a well&#x02010;known animal model of cholestasis (Johnstone and Lee&#x000a0;<xref rid="bmc70119-bib-0016" ref-type="bibr">1976</xref>). It is also known that patients with cholestasis occur in conjunction with vitamin D deficiency due to impaired intestinal vitamin D absorption, which results from decreased secretion of bile acid into the duodenum (Chongthavornvasana et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0004" ref-type="bibr">2023</xref>). Based on these two observations, we thought that BDL rat could be a vitamin D deficiency&#x02010;model. Blood was taken from the postcava under isoflurane anesthesia. After standing at room temperature (<italic toggle="yes">ca.</italic> 20&#x000b0;C) for 30&#x02009;min, the blood was centrifuged at 2000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> (4&#x000b0;C, 30&#x02009;min) to separate the serum. The brain (1.4&#x02013;1.7&#x02009;g) was eviscerated immediately after the blood collection and ultrasonically homogenized in saline (10&#x02009;mL). The homogenate was stirred into ethanol (10&#x02009;mL), then centrifuged at 1500&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic> for 5&#x02009;min. The supernatant was transferred to another test tube, then diluted with ethanol to adjust the concentration to 33.3&#x02009;mg tissue/mL. This solution was described as the &#x0201c;brain extract&#x0201d; in this study. The serum sample and the brain extract were stored at &#x02212;30&#x000b0;C before use. All animal care and use were approved by the Institutional Animal Care and Use Committee of Tokyo University of Science (approved no. Y22022).</p></sec><sec id="bmc70119-sec-0006"><label>2.4</label><title>Pretreatment Procedure of Brain Extract</title><p>The IS (10&#x02009;pg) was added to the brain extract (1.5&#x02009;mL, corresponding to 50&#x02009;mg of brain tissue), and this mixture was diluted with water (3.5&#x02009;mL), then passed through a Strata&#x02010;X cartridge. After washing the cartridge with water (2&#x02009;mL) and 70% (v/v) methanol (1&#x02009;mL), 25(OH)D<sub>3</sub> and IS were eluted with ethyl acetate (1&#x02009;mL). After evaporation of the solvent at 40&#x000b0;C under N<sub>2</sub>, the residue was immediately dissolved in chloroform (0.3&#x02009;mL), then loaded on an InertSep SI cartridge. After washing the cartridge with chloroform (2&#x02009;mL), 25(OH)D<sub>3</sub> and IS were eluted with chloroform&#x02010;methanol (30:1, v/v, 2&#x02009;mL). After evaporation of the solvent at 40&#x000b0;C under N<sub>2</sub>, PIPTAD (20&#x02009;&#x003bc;g) in ethyl acetate (100&#x02009;&#x003bc;L) was added to the residue and mixed. This mixture was left to stand at room temperature for 1&#x02009;h. The reaction was terminated by adding ethanol (20&#x02009;&#x003bc;L). After the solvent was evaporated, the residue was dissolved in the mobile phase (40&#x02009;&#x003bc;L), 10&#x02009;&#x003bc;L of which was subjected to LC/ESI&#x02010;MS/MS.</p></sec><sec id="bmc70119-sec-0007"><label>2.5</label><title>Calibration Curve</title><p>Endogenous 25(OH)D<sub>3</sub> was removed from the brain extract (10&#x02009;mL) by stirring overnight with activated charcoal (1.0&#x02009;g). After centrifugation (2000&#x02009;&#x000d7;&#x02009;<italic toggle="yes">g</italic>, 20&#x000b0;C, 10&#x02009;min), the supernatant was used as the calibration curve matrix. The standard 25(OH)D<sub>3</sub> (1.0, 2.0, 5.0, 10, 20 or 50&#x02009;pg, corresponding to 20&#x02013;1000&#x02009;pg/g tissue) and IS (10&#x02009;pg) were spiked in the calibration curve matrix (1.5&#x02009;mL), then the resulting samples were pretreated and derivatized as described in the previous section. The peak area ratio [derivatized 25(OH)D<sub>3</sub>/IS, <italic toggle="yes">y</italic>] was plotted versus the 25(OH)D<sub>3</sub> concentration (ng/g tissue, <italic toggle="yes">x</italic>) with a weighting of 1/<italic toggle="yes">x</italic> to construct the calibration curves.</p></sec><sec id="bmc70119-sec-0008"><label>2.6</label><title>Assay Precision and Accuracy</title><p>The intra&#x02010;assay and interassay precisions were assessed based on the relative standard deviations (RSDs, %) of five repeated measurements on 1&#x02009;day and over 5&#x02009;days, respectively. The intra&#x02010;assay and interassay accuracies were assessed based on the analytical recovery rates on 1&#x02009;day and over 5&#x02009;days, respectively. Two different brain samples were used for the precision and accuracy tests.</p></sec><sec id="bmc70119-sec-0009"><label>2.7</label><title>Recovery Rates During Solid&#x02010;Phase Extraction (SPE)</title><p>The recovery rates were calculated by dividing the peak area ratios [25(OH)D<sub>3</sub>/IS] of the prespiked samples by those of the postspiked samples (detailed in the Supporting Information).</p></sec><sec id="bmc70119-sec-0010"><label>2.8</label><title>Matrix Effect</title><p>The matrix effect was evaluated by the postextraction addition experiment (Thakare et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0030" ref-type="bibr">2016</xref>) (detailed in the Supporting Information).</p></sec><sec id="bmc70119-sec-0011"><label>2.9</label><title>Stability</title><p>The stability of 25(OH)D<sub>3</sub> in the brain extract was assessed by comparing the measured values of five different rats before and after storage at room temperature (<italic toggle="yes">ca.</italic> 20&#x000b0;C) for 24&#x02009;h (short&#x02010;term stability) and at &#x02212;30&#x000b0;C for 5&#x02009;months (long&#x02010;term stability). The stability of the derivatized 25(OH)D<sub>3</sub> in the processed sample was assessed by comparing the measured values of five different rats before and after storage at 20&#x000b0;C in the autosampler for 24&#x02009;h.</p></sec><sec id="bmc70119-sec-0012"><label>2.10</label><title>Quantification of 25(OH)D<sub>3</sub> in Serum</title><p>The serum 25(OH)D<sub>3</sub> was quantified by the LC/ESI&#x02010;MS/MS method developed and validated in our laboratories. Briefly, the serum (10&#x02009;&#x003bc;L) was diluted, deproteinized, then derivatized with PIPTAD. [6,19,19&#x02010;<sup>2</sup>H<sub>3</sub>]&#x02010;25(OH)D<sub>3</sub> was used as the IS. The validation test results were as follows: measurement range, 2.0&#x02013;100&#x02009;ng/mL; linearity, determination coefficient (<italic toggle="yes">r</italic>
<sup>2</sup>)&#x02009;&#x02265;&#x02009;0.999; limit of detection (LOD, S/N&#x02009;=&#x02009;3), 0.28&#x02009;ng/mL; precision (intra&#x02010;assay and interassay RSDs), &#x02264; 5.0%; accuracy (analytical recovery rates), 95.3%&#x02013;101.0%; and matrix effect, 98.7%. The details of the method will be reported elsewhere in the near future.</p></sec></sec><sec id="bmc70119-sec-0013"><label>3</label><title>Results and Discussion</title><sec id="bmc70119-sec-0014"><label>3.1</label><title>LC/ESI&#x02010;MS/MS Behavior of PIPTAD&#x02010;Derivatized 25(OH)D<sub>3</sub>
</title><p>25(OH)D<sub>3</sub> was derivatized with PIPTAD in the same way as reported in a previous study (Takada et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0029" ref-type="bibr">2023</xref>). A protonated molecule ([M&#x02009;+&#x02009;H]<sup>+</sup>, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 659.6) was produced from the derivatized 25(OH)D<sub>3</sub> [25(OH)D<sub>3</sub>&#x02010;PIPTAD] as the base peak in the positive ESI&#x02010;MS. The collision&#x02010;induced dissociation (CID) of this protonated molecule gave a characteristic fragment ion at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 381.3 with a sufficient intensity as the result of cleavage of the C&#x02010;6&#x02013;7 bond of the vitamin D skeleton (Figures&#x000a0;<xref rid="bmc70119-fig-0001" ref-type="fig">1</xref> and <xref rid="bmc70119-supitem-0001" ref-type="supplementary-material">S1a</xref>). Based on these results, the SRM mode with the transition of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 659.6&#x02009;&#x02192;&#x02009;381.3 was used for quantifying 25(OH)D<sub>3</sub>. The derivatized IS showed similar ESI&#x02010;MS and ESI&#x02010;MS/MS behaviors.</p><p>25(OH)D<sub>3</sub>&#x02010;PIPTAD consisted of the 6<italic toggle="yes">R</italic>&#x02010; and 6<italic toggle="yes">S</italic>&#x02010;isomers in the same way as the derivatives with other Cookson&#x02010;type reagents (Higashi and Shimada&#x000a0;<xref rid="bmc70119-bib-0009" ref-type="bibr">2017</xref>). Therefore, 25(OH)D<sub>3</sub>&#x02010;PIPTAD gave two peaks at 4.6 and 5.5&#x02009;min under the stated LC conditions (Figure&#x000a0;<xref rid="bmc70119-fig-0002" ref-type="fig">2</xref>). It has been reported that the 6<italic toggle="yes">S</italic>&#x02010;isomer is the major product in the reaction of 25(OH)D<sub>3</sub> with various Cookson&#x02010;type reagents (Shimizu et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0027" ref-type="bibr">1995</xref>) and this isomer [retention time (<italic toggle="yes">t</italic>
<sub>R</sub>), 5.5&#x02009;min] was used for the quantification of 25(OH)D<sub>3</sub> in this study.</p><fig position="float" fig-type="FIGURE" id="bmc70119-fig-0002"><label>FIGURE 2</label><caption><p>SRM chromatograms of 25(OH)D<sub>3</sub>, 3&#x02010;<italic toggle="no">epi</italic>&#x02010;25(OH)D<sub>3</sub> and IS as PIPTAD&#x02010;derivatives. (a) Authentic standards. A mixture of 25(OH)D<sub>3</sub> and 3&#x02010;<italic toggle="no">epi</italic>&#x02010;25(OH)D<sub>3</sub> (100&#x02009;pg each) was derivatized and dissolved in the mobile phase (100&#x02009;&#x003bc;L), then 10&#x02009;&#x003bc;L of which was injected into the LC/MS/MS. Red solid peaks: derivatized 25(OH)D<sub>3</sub> and blue diagonal peaks: derivatized 3&#x02010;<italic toggle="no">epi</italic>&#x02010;25(OH)D<sub>3</sub>. (b) Brain sample spiked with IS. The measured 25(OH)D<sub>3</sub> concentration was 174&#x02009;pg/g tissue.</p></caption><graphic xlink:href="BMC-39-e70119-g004" position="anchor" id="jats-graphic-3"/></fig><p>For the quantification of 25(OH)D<sub>3</sub> in biological samples, one of the complicated problems is the potential interference from 3&#x02010;<italic toggle="yes">epi</italic>&#x02010;25(OH)D<sub>3</sub>, leading to overestimation of the true 25(OH)D<sub>3</sub> concentrations (Bailey et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0002" ref-type="bibr">2013</xref>; Higashi and Shimada&#x000a0;<xref rid="bmc70119-bib-0009" ref-type="bibr">2017</xref>). As shown in Figure&#x000a0;<xref rid="bmc70119-fig-0002" ref-type="fig">2a</xref>, the PIPTAD&#x02010;derivatized 3&#x02010;<italic toggle="yes">epi</italic>&#x02010;25(OH)D<sub>3</sub> was eluted at 4.9 and 5.1&#x02009;min as the twin peaks (we could not determine which is the 6<italic toggle="yes">R</italic>&#x02010; or 6<italic toggle="yes">S</italic>&#x02010;isomer) and satisfactorily separated from 25(OH)D<sub>3</sub>&#x02010;PIPTAD; the resolution value was calculated to be 1.51 based on the widths at half height of the neighboring peaks (<italic toggle="yes">t</italic>
<sub>R</sub> 5.1 and 5.5&#x02009;min). This good separation became possible due to the combination of the PIPTAD derivatization and use of the Ascentis Express 90&#x02009;&#x000c5; C18 column packed with superficially porous particles. Thus, the developed method had a tolerance for interference from 3&#x02010;<italic toggle="yes">epi</italic>&#x02010;25(OH)D<sub>3</sub>.</p><p>The effect of the PIPTAD derivatization on the ESI&#x02010;MS/MS detectability of 25(OH)D<sub>3</sub> was evaluated by comparing the S/Ns before and after the derivatization. In this experiment, 2.5 fmol each of the intact (underivatized) and derivatized 25(OH)D<sub>3</sub> were injected into the LC/ESI&#x02010;MS/MS. The S/N value of 25(OH)D<sub>3</sub>&#x02010;PIPTAD was 203&#x02009;&#x000b1;&#x02009;12 [mean &#x000b1; standard deviation (SD), <italic toggle="yes">n</italic>&#x02009;=&#x02009;3], which was 50 times greater than that of the intact 25(OH)D<sub>3</sub> (S/N, 4.1&#x02009;&#x000b1;&#x02009;0.3). As will be shown later, the trace 25(OH)D<sub>3</sub> in the brain could be quantified due to this detectability enhancing effect.</p></sec><sec id="bmc70119-sec-0015"><label>3.2</label><title>Discrimination Between 25(OH)D<sub>3</sub> and Oxysterols by PIPTAD Derivatization</title><p>As mentioned in Section&#x000a0;<xref rid="bmc70119-sec-0001" ref-type="sec">1</xref>, oxysterols are abundant in the brain tissue (Karu et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0017" ref-type="bibr">2011</xref>; Meljon et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0019" ref-type="bibr">2013</xref>). Monohydroxycholest&#x02010;4&#x02010;ene&#x02010;3&#x02010;ones, such as 7&#x003b1;&#x02010;hydroxycholestenone (Mutemberezi et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0021" ref-type="bibr">2016</xref>), and monohydroxy&#x02010;7&#x02010;dehydrocholesterols, such as 4&#x003b2;(OH)&#x02010;7&#x02010;DHC (Meljon et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0019" ref-type="bibr">2013</xref>), are potential endogenous oxysterols and have the same molecular weights as 25(OH)D<sub>3</sub>; therefore, the interference from these oxysterols was of concern for the quantification of 25(OH)D<sub>3</sub> in the brain. However, the monohydroxycholest&#x02010;4&#x02010;ene&#x02010;3&#x02010;ones did not undergo a reaction with PIPTAD due to a lack of the <italic toggle="yes">s</italic>&#x02010;<italic toggle="yes">cis</italic>&#x02010;diene (Figure&#x000a0;<xref rid="bmc70119-fig-0003" ref-type="fig">3</xref>). Although the monohydroxy&#x02010;7&#x02010;dehydrocholesterols produce derivatives after the reaction with PIPTAD, the derivatives showed a different fragmentation pattern from 25(OH)D<sub>3</sub>&#x02010;PIPTAD during the CID (Figures&#x000a0;<xref rid="bmc70119-fig-0003" ref-type="fig">3</xref> and <xref rid="bmc70119-supitem-0001" ref-type="supplementary-material">S1b</xref>). As demonstrated in the prior section, 25(OH)D<sub>3</sub>&#x02010;PIPTAD gave the product ion at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 381.3 resulting from cleavage of the C&#x02013;6&#x02013;7 bond of the vitamin D skeleton (Figure&#x000a0;<xref rid="bmc70119-fig-0001" ref-type="fig">1</xref>), whereas 4&#x003b2;(OH)&#x02010;7&#x02010;DHC&#x02010;PIPTAD did not give this product ion but gave the product ions at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 203.1 and 259.1, which were derived from the PIPTAD moiety. Accordingly, when the SRM of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 659.6&#x02009;&#x02192;&#x02009;381.3 was used, 25(OH)D<sub>3</sub>&#x02010;PIPTAD could be specifically detected even in the presence of a large amount of isomeric oxysterols. Thus, the PIPTAD derivatization significantly enhanced the specificity for the brain assay.</p><fig position="float" fig-type="FIGURE" id="bmc70119-fig-0003"><label>FIGURE 3</label><caption><p>Reaction of 7&#x003b1;&#x02010;hydroxycholestenone and 4&#x003b2;(OH)&#x02010;7&#x02010;DHC with PIPTAD. Structures of product ions from the derivatized 4&#x003b2;(OH)&#x02010;7&#x02010;DHC are also shown.</p></caption><graphic xlink:href="BMC-39-e70119-g001" position="anchor" id="jats-graphic-5"/></fig></sec><sec id="bmc70119-sec-0016"><label>3.3</label><title>Pretreatment of Brain Extract</title><p>The brain extract corresponding to 50&#x02009;mg of brain tissue was sequentially purified using reversed phase and normal phase SPE cartridges. The recovery rate of 25(OH)D<sub>3</sub> during the sequential SPE process was 63.2&#x02009;&#x000b1;&#x02009;1.4% (mean &#x000b1; SD from five different brain samples). Thus, 25(OH)D<sub>3</sub> was acceptably and reproducibly recovered from the brain extract sample. The elution fraction was derivatized with PIPTAD after evaporation to dryness.</p><p>The typical chromatograms of the pretreated brain sample are shown in Figure&#x000a0;<xref rid="bmc70119-fig-0002" ref-type="fig">2b</xref>. The peak of the major isomer of 25(OH)D<sub>3</sub>&#x02010;PIPTAD was clearly observed (<italic toggle="yes">t</italic>
<sub>R</sub> 5.5&#x02009;min). No significant matrix effect was observed for 25(OH)D<sub>3</sub> (100.3&#x02009;&#x000b1;&#x02009;1.5%, mean &#x000b1; SD, <italic toggle="yes">n</italic>&#x02009;=&#x02009;5) and IS (95.2&#x02009;&#x000b1;&#x02009;2.8%) despite the complexity of the brain matrix. This result demonstrated that the two&#x02010;step SPE&#x02010;based pretreatment procedure worked well to remove the brain&#x02010;derived substances that cause ion suppression/enhancement, although the procedure was time&#x02010;consuming. The LOD (S/N&#x02009;=&#x02009;3) was calculated to be 5&#x02009;pg/g tissue based on the measured concentrations and S/N values of the brain samples of the BDL rats.</p></sec><sec id="bmc70119-sec-0017"><label>3.4</label><title>Calibration Curve</title><p>A good linearity (<italic toggle="yes">r</italic>
<sup>2</sup>&#x02009;&#x0003e;&#x02009;0.999) and reproducibility (RSD of slope, 1.7%) were obtained within the range of 20&#x02013;1000&#x02009;pg/g tissue; the regression formula was <italic toggle="yes">y</italic>&#x02009;=&#x02009;(4.5657&#x02009;&#x000b1;&#x02009;0.0794)&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>
<italic toggle="yes">x</italic>&#x02009;+&#x02009;(0.0098&#x02009;&#x000b1;&#x02009;0.0190)&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> (the slope and <italic toggle="yes">y</italic>&#x02010;intercept were given as the mean &#x000b1; SD, <italic toggle="yes">n</italic>&#x02009;=&#x02009;5).</p></sec><sec id="bmc70119-sec-0018"><label>3.5</label><title>Assay Precision and Accuracy</title><p>As shown in Table&#x000a0;<xref rid="bmc70119-tbl-0001" ref-type="table">1</xref>, the maximum RSD value in the intra&#x02010;assay and interassay precision tests was 4.0%, which was much lower than the generally accepted criterion (&#x02264; 15%). The analytical recovery rates ranged from 97.7% to 101.2%, which fell within the guidelines (100&#x02009;&#x000b1;&#x02009;15%). Thus, a highly precise and accurate method was established.</p><table-wrap position="float" id="bmc70119-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Assay precision and accuracy.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">Brain A</th><th align="center" valign="bottom" rowspan="1" colspan="1">Brain B</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Intra&#x02010;assay</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Precision</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Measured (pg/g tissue)<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">66&#x02009;&#x000b1;&#x02009;1</td><td align="center" valign="top" rowspan="1" colspan="1">175&#x02009;&#x000b1;&#x02009;7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RSD (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td><td align="center" valign="top" rowspan="1" colspan="1">4.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Accuracy (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+ 50&#x02009;pg/g tissue spiked<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">97.8&#x02009;&#x000b1;&#x02009;4.4</td><td align="center" valign="top" rowspan="1" colspan="1">Not examined</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+100&#x02009;pg/g tissue spiked<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">99.3&#x02009;&#x000b1;&#x02009;3.9</td><td align="center" valign="top" rowspan="1" colspan="1">98.4&#x02009;&#x000b1;&#x02009;3.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+ 200&#x02009;pg/g tissue spiked<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">Not examined</td><td align="center" valign="top" rowspan="1" colspan="1">101.2&#x02009;&#x000b1;&#x02009;4.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Interassay</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Precision</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Measured (pg/g tissue)<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">67&#x02009;&#x000b1;&#x02009;1</td><td align="center" valign="top" rowspan="1" colspan="1">180&#x02009;&#x000b1;&#x02009;7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RSD (%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td><td align="center" valign="top" rowspan="1" colspan="1">3.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Accuracy (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+ 50&#x02009;pg/g tissue spiked<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">98.6&#x02009;&#x000b1;&#x02009;2.3</td><td align="center" valign="top" rowspan="1" colspan="1">Not examined</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+ 100&#x02009;pg/g tissue spiked<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">101.0&#x02009;&#x000b1;&#x02009;1.4</td><td align="center" valign="top" rowspan="1" colspan="1">99.4&#x02009;&#x000b1;&#x02009;3.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">+ 200&#x02009;pg/g tissue spiked<xref rid="bmc70119-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="center" valign="top" rowspan="1" colspan="1">Not examined</td><td align="center" valign="top" rowspan="1" colspan="1">97.7&#x02009;&#x000b1;&#x02009;2.5</td></tr></tbody></table><table-wrap-foot id="bmc70119-ntgp-0002"><fn id="bmc70119-note-0002"><label>
<sup>a</sup>
</label><p>Mean &#x000b1; SD (<italic toggle="yes">n</italic>&#x02009;=&#x02009;5).</p></fn></table-wrap-foot></table-wrap></sec><sec id="bmc70119-sec-0019"><label>3.6</label><title>Stability</title><p>There were no significant changes in the 25(OH)D<sub>3</sub> concentration in the brain extract during the short&#x02010;term storage (at 20&#x000b0;C for 24&#x02009;h; 98.7&#x02009;&#x000b1;&#x02009;2.6%, mean &#x000b1; SD, <italic toggle="yes">n</italic>&#x02009;=&#x02009;5) and long&#x02010;term storage (at &#x02212;30&#x000b0;C for 5&#x02009;months; 98.3&#x02009;&#x000b1;&#x02009;5.1%). The processed samples were also stable at 20&#x000b0;C for at least 24&#x02009;h (100.6&#x02009;&#x000b1;&#x02009;5.3%).</p></sec><sec id="bmc70119-sec-0020"><label>3.7</label><title>Determination of 25(OH)D<sub>3</sub> Concentrations in the Rat Brain and Effect of the Serum Concentrations on the Brain Concentrations</title><p>Figure&#x000a0;<xref rid="bmc70119-fig-0004" ref-type="fig">4</xref> shows the distribution of the brain and serum 25(OH)D<sub>3</sub> concentrations of the normal, fasted, and BDL rats (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6 each) and the correlation between the brain and serum levels. The mean concentrations with the SD values were 147&#x02009;&#x000b1;&#x02009;19, 140&#x02009;&#x000b1;&#x02009;22, and 58&#x02009;&#x000b1;&#x02009;12&#x02009;pg/g tissue for the normal, fasted, and BDL rats, respectively. The serum 25(OH)D<sub>3</sub> concentrations were extremely higher than the brain concentrations: 17.5&#x02009;&#x000b1;&#x02009;1.7, 17.4&#x02009;&#x000b1;&#x02009;2.4, and 5.5&#x02009;&#x000b1;&#x02009;1.0&#x02009;ng/mL (mean &#x000b1; SD) for normal, fasted, and BDL rats, respectively. The brain 25(OH)D<sub>3</sub> concentration&#x02010;to&#x02010;serum 25(OH)D<sub>3</sub> concentration ratios (B/S ratios) ranged from 1/62 to 1/167. The circulating 25(OH)D<sub>3</sub> exists in three forms with the approximate ratio of 85%&#x02013;90% as the vitamin D binding protein (DBP)&#x02010;bound form, 10%&#x02013;15% as the albumin&#x02010;bound form, and 0.03% or less in the protein&#x02010;unbound (free) form (Ishimine et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0015" ref-type="bibr">2022</xref>). DBP&#x02010; and albumin&#x02010;bound 25(OH)D<sub>3</sub> cannot enter the brain because proteins hardly cross the blood&#x02013;brain barrier, whereas free fraction of the circulating 25(OH)D<sub>3</sub> can cross the blood&#x02013;brain barrier by passive diffusion due to its high hydrophobicity and low molecular weight. Given this extremely low rate (0.03%) of the free form, the above&#x02010;mentioned low B/S ratio (1/62&#x02013;1/167) was a logical outcome.</p><fig position="float" fig-type="FIGURE" id="bmc70119-fig-0004"><label>FIGURE 4</label><caption><p>Scatter diagrams to show the distribution of the brain and serum 25(OH)D<sub>3</sub> concentrations and the correlation between the two. Red circle; normal rat, blue triangle; fasted rat and green diamond; BDL rat (<italic toggle="no">n</italic>&#x02009;=&#x02009;6 each).</p></caption><graphic xlink:href="BMC-39-e70119-g002" position="anchor" id="jats-graphic-7"/></fig><p>For quantifying the brain 25(OH)D<sub>3</sub>, the small residual blood in the brain tissue was of concern because it was impossible to completely remove the blood from the brain sample. This was one of the limitations of this study. If the DBP concentration is significantly lower than the 25(OH)D<sub>3</sub> concentration in the brain sample, the possibility that blood contamination is a major cause of the detection of 25(OH)D<sub>3</sub> in the brain sample can be excluded. The comparison of the DBP and 25(OH)D<sub>3</sub> concentrations in the brain sample merits further research.</p><p>In our previous study (Shibuya et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0026" ref-type="bibr">2024</xref>), the concentrations of bile acids were determined in the brain samples collected in the similar way as this study and compared to their serum concentrations. The B/S ratios of cholic acid and lithocholic acid in normal rats (<italic toggle="yes">n</italic>&#x02009;=&#x02009;12) were 1/39&#x02013;1/96 and 1/17&#x02013;1/56, respectively. If 25(OH)D<sub>3</sub> in the residual blood was the main source of 25(OH)D<sub>3</sub> detected in the brain sample, its B/S ratios would be in the same range as those of the bile acids. However, the B/S ratios of 25(OH)D<sub>3</sub> (1/62&#x02013;1/167) significantly differed from those of the bile acids. Based on these observations, we inferred that the blood contamination was not the major cause of the detection of 25(OH)D<sub>3</sub> in the brain sample.</p><p>A 24&#x02010;h fasting had virtually no influence on the brain and serum 25(OH)D<sub>3</sub> concentrations; this could be due to the relatively long half&#x02010;life (2&#x02013;3&#x02009;weeks) of the circulating 25(OH)D<sub>3</sub> (Holick&#x000a0;<xref rid="bmc70119-bib-0012" ref-type="bibr">2009</xref>). On the other hand, the bile duct ligation treatment significantly decreased the 25(OH)D<sub>3</sub> concentrations in both the brain and serum. In the BDL rats, bile acids, which are essential for absorption of the lipid&#x02010;soluble nutrients including vitamin D, are not secreted into the duodenum; this deficient secretion of bile acids causes the decreased absorption of vitamin D<sub>3</sub> from their diet. Even the fur&#x02010;bearing animals can synthesize vitamin D<sub>3</sub> on their skin when they are exposed to UV&#x02010;B (Carpenter and Zhao&#x000a0;<xref rid="bmc70119-bib-0003" ref-type="bibr">1999</xref>; Hym&#x000f8;ller and Jensen&#x000a0;<xref rid="bmc70119-bib-0014" ref-type="bibr">2010</xref>). However, the rats used in this study were housed under a conventional LED lamp, which does not emit UV&#x02010;B, during the light period (08:00&#x02013;20:00&#x02009;h). Therefore, it is presumed that the photochemically synthesized vitamin D<sub>3</sub> on their skin is very limited, and the main source of vitamin D<sub>3</sub> is their diet for the rats used in this study. Therefore, the BDL rat can be the vitamin D deficiency&#x02010;model. These rats were kept in a state of bile duct ligation for 7&#x02009;days, and in the meantime, the serum 25(OH)D<sub>3</sub> levels decreased, which would cause the subsequent decreased brain 25(OH)D<sub>3</sub> levels. Thus, our study ensured that the serum 25(OH)D<sub>3</sub> concentrations have a significant effect on the brain 25(OH)D<sub>3</sub> levels. When all the rats were lumped together (<italic toggle="yes">n</italic>&#x02009;=&#x02009;18), there was a positive correlation between the brain and serum 25(OH)D<sub>3</sub> concentrations with a correlation coefficient of 0.872 (Figure&#x000a0;<xref rid="bmc70119-fig-0004" ref-type="fig">4</xref>); this result agreed well with that of the previous study (Xue et&#x000a0;al.&#x000a0;<xref rid="bmc70119-bib-0033" ref-type="bibr">2015</xref>).</p></sec></sec><sec sec-type="conclusions" id="bmc70119-sec-0021"><label>4</label><title>Conclusion</title><p>The LC/ESI&#x02010;MS/MS method was developed and validated for quantifying 25(OH)D<sub>3</sub> in the rat brain tissue. The PIPTAD derivatization enhanced the assay sensitivity and specificity. Based on the developed method, the brain 25(OH)D<sub>3</sub> was quantified in the normal, fasted, and BDL rats. The brain 25(OH)D<sub>3</sub> concentrations were slightly over 100&#x02009;pg/g tissue under the normal conditions and were extremely lower than the serum concentrations. The bile duct ligation caused the decreased serum 25(OH)D<sub>3</sub> level, which produced the subsequent decreased brain 25(OH)D<sub>3</sub> level. These results may provide evidence that the serum 25(OH)D<sub>3</sub> concentration has a significant effect on its brain level.</p></sec><sec sec-type="COI-statement" id="bmc70119-sec-0023"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="bmc70119-supitem-0001" position="float" content-type="local-data"><caption><p>
<bold>Figure S1.</bold> Product ion spectrum of (a) PIPTAD&#x02010;derivatized 25(OH)D<sub>3</sub> and (b) 4&#x003b2;(OH)&#x02010;7&#x02010;DHC.</p></caption><media xlink:href="BMC-39-e70119-s001.docx"/></supplementary-material></sec></body><back><ack id="bmc70119-sec-0022"><title>Acknowledgments</title><p>This study was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 23K06070 [to T.H.]).</p></ack><sec sec-type="data-availability" id="bmc70119-sec-0025"><title>Data Availability Statement</title><p>Data will be made available upon request.</p></sec><ref-list content-type="cited-references" id="bmc70119-bibl-0001"><title>References</title><ref id="bmc70119-bib-0001"><mixed-citation publication-type="journal" id="bmc70119-cit-0001">
<string-name>
<surname>Ahonen</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>F. B.</given-names>
<surname>Maire</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Savolainen</surname>
</string-name>, et&#x000a0;al. <year>2014</year>. &#x0201c;<article-title>Analysis of Oxysterols and Vitamin D Metabolites in Mouse Brain and Cell Line Samples by Ultra&#x02010;High&#x02010;Performance Liquid Chromatography&#x02010;Atmospheric Pressure Photoionization&#x02010;Mass Spectrometry</article-title>.&#x0201d; <source>Journal of Chromatography A</source>
<volume>1364</volume>: <fpage>214</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.chroma.2014.08.088</pub-id>.<pub-id pub-id-type="pmid">25204266</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0002"><mixed-citation publication-type="journal" id="bmc70119-cit-0002">
<string-name>
<surname>Bailey</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Veljkovic</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Yazdanpanah</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Adeli</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Analytical Measurement and Clinical Relevance of Vitamin D<sub>3</sub> C3&#x02010;Epimer</article-title>.&#x0201d; <source>Clinical Biochemistry</source>
<volume>46</volume>: <fpage>190</fpage>&#x02013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinbiochem.2012.10.037</pub-id>.<pub-id pub-id-type="pmid">23153571</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0003"><mixed-citation publication-type="journal" id="bmc70119-cit-0003">
<string-name>
<surname>Carpenter</surname>, <given-names>K. J.</given-names>
</string-name>, and <string-name>
<given-names>L.</given-names>
<surname>Zhao</surname>
</string-name>. <year>1999</year>. &#x0201c;<article-title>Forgotten Mysteries in the Early History of Vitamin D</article-title>.&#x0201d; <source>Journal of Nutrition</source>
<volume>129</volume>: <fpage>923</fpage>&#x02013;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1093/jn/129.5.923</pub-id>.<pub-id pub-id-type="pmid">10222380</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0004"><mixed-citation publication-type="journal" id="bmc70119-cit-0004">
<string-name>
<surname>Chongthavornvasana</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Lertudomphonwanit</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Mahachoklertwattana</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Korwutthikulrangsri</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Determination of Optimal Vitamin D Dosage in Children With Cholestasis</article-title>.&#x0201d; <source>BMC Pediatrics</source>
<volume>23</volume>: <elocation-id>313</elocation-id>. <pub-id pub-id-type="doi">10.1186/s12887-023-04113-y</pub-id>.<pub-id pub-id-type="pmid">37344793</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0005"><mixed-citation publication-type="journal" id="bmc70119-cit-0005">
<string-name>
<surname>Eyles</surname>, <given-names>D. W.</given-names>
</string-name>, <string-name>
<given-names>T. H.</given-names>
<surname>Burne</surname>
</string-name>, and <string-name>
<given-names>J. J.</given-names>
<surname>McGrath</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Vitamin D, Effects on Brain Development, Adult Brain Function and the Links Between Low Levels of Vitamin D and Neuropsychiatric Disease</article-title>.&#x0201d; <source>Frontiers in Neuroendocrinology</source>
<volume>34</volume>: <fpage>47</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2012.07.001</pub-id>.<pub-id pub-id-type="pmid">22796576</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0006"><mixed-citation publication-type="journal" id="bmc70119-cit-0006">
<string-name>
<surname>Eyles</surname>, <given-names>D. W.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Smith</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kinobe</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hewison</surname>
</string-name>, and <string-name>
<given-names>J. J.</given-names>
<surname>McGrath</surname>
</string-name>. <year>2005</year>. &#x0201c;<article-title>Distribution of the Vitamin D Receptor and 1&#x003b1;&#x02010;Hydroxylase in Human Brain</article-title>.&#x0201d; <source>Journal of Chemical Neuroanatomy</source>
<volume>29</volume>: <fpage>21</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2004.08.006</pub-id>.<pub-id pub-id-type="pmid">15589699</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0007"><mixed-citation publication-type="journal" id="bmc70119-cit-0007">
<string-name>
<surname>Fu</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<given-names>G. G.</given-names>
<surname>Dolnikowski</surname>
</string-name>, <string-name>
<given-names>W. B.</given-names>
<surname>Patterson</surname>
</string-name>, et&#x000a0;al. <year>2019</year>. &#x0201c;<article-title>Determination of Vitamin D and Its Metabolites in Human Brain Using an Ultra&#x02010;Pressure LC&#x02010;Tandem Mass Spectra Method</article-title>.&#x0201d; <source>Current Developments in Nutrition</source>
<volume>3</volume>: <elocation-id>nzz074</elocation-id>. <pub-id pub-id-type="doi">10.1093/cdn/nzz074</pub-id>.<pub-id pub-id-type="pmid">31334481</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0008"><mixed-citation publication-type="journal" id="bmc70119-cit-0008">
<string-name>
<surname>Harms</surname>, <given-names>L. R.</given-names>
</string-name>, <string-name>
<given-names>T. H.</given-names>
<surname>Burne</surname>
</string-name>, <string-name>
<given-names>D. W.</given-names>
<surname>Eyles</surname>
</string-name>, and <string-name>
<given-names>J. J.</given-names>
<surname>McGrath</surname>
</string-name>. <year>2011</year>. &#x0201c;<article-title>Vitamin D and the Brain</article-title>.&#x0201d; <source>Best Practice &#x00026; Research. Clinical Endocrinology &#x00026; Metabolism</source>
<volume>25</volume>: <fpage>657</fpage>&#x02013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2011.05.009</pub-id>.<pub-id pub-id-type="pmid">21872806</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0009"><mixed-citation publication-type="journal" id="bmc70119-cit-0009">
<string-name>
<surname>Higashi</surname>, <given-names>T.</given-names>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Shimada</surname>
</string-name>. <year>2017</year>. &#x0201c;<article-title>Application of Cookson&#x02010;Type Reagents for Biomedical HPLC and LC/MS Analyses: A Brief Overview</article-title>.&#x0201d; <source>Biomedical Chromatography</source>
<volume>31</volume>: <elocation-id>e3808</elocation-id>. <pub-id pub-id-type="doi">10.1002/bmc.3808</pub-id>.</mixed-citation></ref><ref id="bmc70119-bib-0010"><mixed-citation publication-type="journal" id="bmc70119-cit-0010">
<string-name>
<surname>Higashi</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Shimada</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Toyo'oka</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Advances in Determination of Vitamin D Related Compounds in Biological Samples Using Liquid Chromatography&#x02010;Mass Spectrometry: A Review</article-title>.&#x0201d; <source>Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences</source>
<volume>878</volume>: <fpage>1654</fpage>&#x02013;<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchromb.2009.11.026</pub-id>.<pub-id pub-id-type="pmid">19962356</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0011"><mixed-citation publication-type="journal" id="bmc70119-cit-0011">
<string-name>
<surname>Higashi</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Tanaka</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Tsubura</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Nishimoto&#x02010;Kusunose</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>Conversion of 5&#x003b1;&#x02010;Androstane&#x02010;3&#x003b1;,17&#x003b2;&#x02010;Diol to bis[(4&#x02010;dimethylamino)phenyl carbamate] Derivative for Sensitive Determination of Its Rat Brain Level by LC/ESI&#x02010;MS/MS</article-title>.&#x0201d; <source>Rapid Communications in Mass Spectrometry</source>
<volume>38</volume>: <elocation-id>e9875</elocation-id>. <pub-id pub-id-type="doi">10.1002/rcm.9875</pub-id>.<pub-id pub-id-type="pmid">39049483</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0012"><mixed-citation publication-type="journal" id="bmc70119-cit-0012">
<string-name>
<surname>Holick</surname>, <given-names>M. F.</given-names>
</string-name>
<year>2009</year>. &#x0201c;<article-title>Vitamin D Status: Measurement, Interpretation, and Clinical Application</article-title>.&#x0201d; <source>Annals of Epidemiology</source>
<volume>19</volume>: <fpage>73</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2007.12.001</pub-id>.<pub-id pub-id-type="pmid">18329892</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0013"><mixed-citation publication-type="journal" id="bmc70119-cit-0013">
<string-name>
<surname>Hu</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Cong</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Liu</surname>
</string-name>, and <string-name>
<given-names>Z.</given-names>
<surname>An</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>High Throughput UHPLC&#x02010;MS/MS Method for the Simultaneous Quantification of Six Vitamin D Metabolites: Application for Vitamin D Determination in Patients After Liver or Kidney Transplantation</article-title>.&#x0201d; <source>Analytical Methods</source>
<volume>12</volume>: <fpage>5591</fpage>&#x02013;<lpage>5600</lpage>. <pub-id pub-id-type="doi">10.1039/d0ay01088j</pub-id>.<pub-id pub-id-type="pmid">33174880</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0014"><mixed-citation publication-type="journal" id="bmc70119-cit-0014">
<string-name>
<surname>Hym&#x000f8;ller</surname>, <given-names>L.</given-names>
</string-name>, and <string-name>
<given-names>S. K.</given-names>
<surname>Jensen</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Vitamin D<sub>3</sub> Synthesis in the Entire Skin Surface of Dairy Cows Despite Hair Coverage</article-title>.&#x0201d; <source>Journal of Dairy Science</source>
<volume>93</volume>: <fpage>2025</fpage>&#x02013;<lpage>2029</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2009-2991</pub-id>.<pub-id pub-id-type="pmid">20412916</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0015"><mixed-citation publication-type="journal" id="bmc70119-cit-0015">
<string-name>
<surname>Ishimine</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Ota</surname>
</string-name>, et&#x000a0;al. <year>2022</year>. &#x0201c;<article-title>Development of Free 25&#x02010;Hydroxyvitamin D<sub>3</sub> Assay Method Using Liquid Chromatography&#x02010;Tandem Mass Spectrometry</article-title>.&#x0201d; <source>Bioscience Reports</source>
<volume>42</volume>: <elocation-id>BSR20221326</elocation-id>. <pub-id pub-id-type="doi">10.1042/BSR20221326</pub-id>.<pub-id pub-id-type="pmid">36107130</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0016"><mixed-citation publication-type="journal" id="bmc70119-cit-0016">
<string-name>
<surname>Johnstone</surname>, <given-names>J. M.</given-names>
</string-name>, and <string-name>
<given-names>E. G.</given-names>
<surname>Lee</surname>
</string-name>. <year>1976</year>. &#x0201c;<article-title>A Quantitative Assessment of the Structural Changes the Rat's Liver Following Obstruction of the Common Bile Duct</article-title>.&#x0201d; <source>British Journal of Experimental Pathology</source>
<volume>57</volume>: <fpage>85</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">1268043</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0017"><mixed-citation publication-type="journal" id="bmc70119-cit-0017">
<string-name>
<surname>Karu</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Turton</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>W. J.</given-names>
<surname>Griffiths</surname>
</string-name>. <year>2011</year>. &#x0201c;<article-title>Nano&#x02010;Liquid Chromatography&#x02010;Tandem Mass Spectrometry Analysis of Oxysterols in Brain: Monitoring of Cholesterol Autoxidation</article-title>.&#x0201d; <source>Chemistry and Physics of Lipids</source>
<volume>164</volume>: <fpage>411</fpage>&#x02013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1016/j.chemphyslip.2011.04.011</pub-id>.<pub-id pub-id-type="pmid">21575613</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0018"><mixed-citation publication-type="journal" id="bmc70119-cit-0018">
<string-name>
<surname>Kawamoto</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Ohmori</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Maekawa</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Shimada</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Mano</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Iida</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>An Efficient Synthesis of 4&#x003b1;&#x02010; and 4&#x003b2;&#x02010;Hydroxy&#x02010;7&#x02010;Dehydrocholesterol, Biomarkers for Patients With and Animal Models of the Smith&#x02010;Lemli&#x02010;Opitz Syndrome</article-title>.&#x0201d; <source>Chemistry and Physics of Lipids</source>
<volume>175&#x02010;176</volume>: <fpage>73</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.chemphyslip.2013.07.004</pub-id>.</mixed-citation></ref><ref id="bmc70119-bib-0019"><mixed-citation publication-type="journal" id="bmc70119-cit-0019">
<string-name>
<surname>Meljon</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>G. L.</given-names>
<surname>Watson</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>C. H.</given-names>
<surname>Shackleton</surname>
</string-name>, and <string-name>
<given-names>W. J.</given-names>
<surname>Griffiths</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Analysis by Liquid Chromatography&#x02010;Mass Spectrometry of Sterols and Oxysterols in Brain of the Newborn <italic toggle="yes">Dhcr7</italic>
<sup>&#x00394;3&#x02010;5/T93M</sup> Mouse: A Model of Smith&#x02010;Lemli&#x02010;Opitz Syndrome</article-title>.&#x0201d; <source>Biochemical Pharmacology</source>
<volume>86</volume>: <fpage>43</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2013.03.003</pub-id>.<pub-id pub-id-type="pmid">23500538</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0020"><mixed-citation publication-type="journal" id="bmc70119-cit-0020">
<string-name>
<surname>Miyamoto</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Kawakami</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Hanafusa</surname>
</string-name>, et&#x000a0;al. <year>2023</year>. &#x0201c;<article-title>Determination of a Serum 25&#x02010;Hydroxyvitamin D Reference Ranges in Japanese Adults Using Fully Automated Liquid Chromatography&#x02010;Tandem Mass Spectrometry</article-title>.&#x0201d; <source>Journal of Nutrition</source>
<volume>153</volume>: <fpage>1253</fpage>&#x02013;<lpage>1264</lpage>. <pub-id pub-id-type="doi">10.1016/j.tjnut.2023.01.036</pub-id>.<pub-id pub-id-type="pmid">36806449</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0021"><mixed-citation publication-type="journal" id="bmc70119-cit-0021">
<string-name>
<surname>Mutemberezi</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Guillemot&#x02010;Legris</surname>
</string-name>, and <string-name>
<given-names>G. G.</given-names>
<surname>Muccioli</surname>
</string-name>. <year>2016</year>. &#x0201c;<article-title>Oxysterols: From Cholesterol Metabolites to Key Mediators</article-title>.&#x0201d; <source>Progress in Lipid Research</source>
<volume>64</volume>: <fpage>152</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.plipres.2016.09.002</pub-id>.<pub-id pub-id-type="pmid">27687912</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0022"><mixed-citation publication-type="journal" id="bmc70119-cit-0022">
<string-name>
<surname>Nishimoto&#x02010;Kusunose</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hirakawa</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Tanaka</surname>
</string-name>, et&#x000a0;al. <year>2023</year>. &#x0201c;<article-title>Drugs Possessing Aryloxypropanamine Pharmacophore, Duloxetine, Dapoxetine and Propranolol, Increase Allopregnanolone in Rat Brain: Possible Involvement of Allopregnanolone in Their Central Nervous System Effects</article-title>.&#x0201d; <source>Steroids</source>
<volume>198</volume>: <elocation-id>109272</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.steroids.2023.109272</pub-id>.<pub-id pub-id-type="pmid">37468115</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0023"><mixed-citation publication-type="journal" id="bmc70119-cit-0023">
<string-name>
<surname>Ogawa</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ooki</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Morohashi</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Yamagata</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Higashi</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>A Novel Cookson&#x02010;Type Reagent for Enhancing Sensitivity and Specificity in Assessment of Infant Vitamin D Status Using Liquid Chromatography/Tandem Mass Spectrometry</article-title>.&#x0201d; <source>Rapid Communications in Mass Spectrometry</source>
<volume>27</volume>: <fpage>2453</fpage>&#x02013;<lpage>2460</lpage>. <pub-id pub-id-type="doi">10.1002/rcm.6708</pub-id>.<pub-id pub-id-type="pmid">24097402</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0024"><mixed-citation publication-type="journal" id="bmc70119-cit-0024">
<string-name>
<surname>Ogawa</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Zhou</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Kimoto</surname>
</string-name>, et&#x000a0;al. <year>2013</year>. &#x0201c;<article-title>An Efficient Synthesis of 7&#x003b1;,12&#x003b1;&#x02010;Dihydroxy&#x02010;4&#x02010;cholesten&#x02010;3&#x02010;one and Its Biological Precursor 7&#x003b1;&#x02010;Hydroxy&#x02010;4&#x02010;cholesten&#x02010;3&#x02010;one: Key Intermediates in Bile Acid Biosynthesis</article-title>.&#x0201d; <source>Steroids</source>
<volume>78</volume>: <fpage>927</fpage>&#x02013;<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2013.05.011</pub-id>.<pub-id pub-id-type="pmid">23707572</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0025"><mixed-citation publication-type="journal" id="bmc70119-cit-0025">
<string-name>
<surname>Rihal</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Khan</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kaur</surname>
</string-name>, <string-name>
<given-names>T. G.</given-names>
<surname>Singh</surname>
</string-name>, and <string-name>
<given-names>M. M.</given-names>
<surname>Abdel&#x02010;Daim</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Therapeutic and Mechanistic Intervention of Vitamin D in Neuropsychiatric Disorders</article-title>.&#x0201d; <source>Psychiatry Research</source>
<volume>317</volume>: <elocation-id>114782</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.psychres.2022.114782</pub-id>.<pub-id pub-id-type="pmid">36049434</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0026"><mixed-citation publication-type="journal" id="bmc70119-cit-0026">
<string-name>
<surname>Shibuya</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Sato</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Nishimoto&#x02010;Kusunose</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Yoshizawa</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Higashi</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>Further Evidence for Blood&#x02010;to&#x02010;Brain Influx of Unconjugated Bile Acids by Passive Diffusion: Determination of Their Brain&#x02010;to&#x02010;Serum Concentration Ratios in Rats by LC/MS/MS</article-title>.&#x0201d; <source>Steroids</source>
<volume>204</volume>: <elocation-id>109397</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.steroids.2024.109397</pub-id>.<pub-id pub-id-type="pmid">38508483</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0027"><mixed-citation publication-type="journal" id="bmc70119-cit-0027">
<string-name>
<surname>Shimizu</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Iwasaki</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Yamada</surname>
</string-name>. <year>1995</year>. &#x0201c;<article-title>New Fluorogenic Dienophile: Synthesis, Reaction with Vitamin D, Vitamin A and Microcystins, and Application to Fluorometric Assays</article-title>.&#x0201d; <source>Yakugaku Zasshi</source>
<volume>115</volume>: <fpage>584</fpage>&#x02013;<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1248/yakushi1947.115.8_584</pub-id>.<pub-id pub-id-type="pmid">7473056</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0028"><mixed-citation publication-type="journal" id="bmc70119-cit-0028">
<string-name>
<surname>Stephenson</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Hunter</surname>
</string-name>, <string-name>
<given-names>P. N.</given-names>
<surname>Shaw</surname>
</string-name>, et&#x000a0;al. <year>2023</year>. &#x0201c;<article-title>A Highly Sensitive LC&#x02010;MS/MS Method for Quantitative Determination of 7 Vitamin D Metabolites in Mouse Brain Tissue</article-title>.&#x0201d; <source>Analytical and Bioanalytical Chemistry</source>
<volume>415</volume>: <fpage>1357</fpage>&#x02013;<lpage>1369</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-023-04527-8</pub-id>.<pub-id pub-id-type="pmid">36705732</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0029"><mixed-citation publication-type="journal" id="bmc70119-cit-0029">
<string-name>
<surname>Takada</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Ogawa</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Yoshida</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Higashi</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Separation and Identification of Monoglucuronides of Vitamin D<sub>3</sub> Metabolites in Urine by Derivatization&#x02010;Assisted LC/ESI&#x02010;MS/MS Using a New Cookson&#x02010;Type Reagent</article-title>.&#x0201d; <source>Analytical Sciences</source>
<volume>39</volume>: <fpage>1053</fpage>&#x02013;<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1007/s44211-023-00350-4</pub-id>.<pub-id pub-id-type="pmid">37131118</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0030"><mixed-citation publication-type="journal" id="bmc70119-cit-0030">
<string-name>
<surname>Thakare</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>Y. S.</given-names>
<surname>Chhonker</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Gautam</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Alamoudi</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Alnouti</surname>
</string-name>. <year>2016</year>. &#x0201c;<article-title>Quantitative Analysis of Endogenous Compounds</article-title>.&#x0201d; <source>Journal of Pharmaceutical and Biomedical Analysis</source>
<volume>128</volume>: <fpage>426</fpage>&#x02013;<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2016.06.017</pub-id>.<pub-id pub-id-type="pmid">27344632</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0031"><mixed-citation publication-type="journal" id="bmc70119-cit-0031">
<string-name>
<surname>Tuckey</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<given-names>C. Y. S.</given-names>
<surname>Cheng</surname>
</string-name>, and <string-name>
<given-names>A. T.</given-names>
<surname>Slominski</surname>
</string-name>. <year>2019</year>. &#x0201c;<article-title>The Serum Vitamin D Metabolome: What We Know and What Is Still to Discover</article-title>.&#x0201d; <source>Journal of Steroid Biochemistry and Molecular Biology</source>
<volume>186</volume>: <fpage>4</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2018.09.003</pub-id>.<pub-id pub-id-type="pmid">30205156</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0032"><mixed-citation publication-type="journal" id="bmc70119-cit-0032">
<string-name>
<surname>Wassif</surname>, <given-names>G. A.</given-names>
</string-name>, <string-name>
<given-names>M. S.</given-names>
<surname>Alrehely</surname>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Alharbi</surname>
</string-name>, and <string-name>
<given-names>A. A.</given-names>
<surname>Aljohani</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>The Impact of Vitamin D on Neuropsychiatric Disorders</article-title>.&#x0201d; <source>Cureus</source>
<volume>15</volume>: <elocation-id>e47716</elocation-id>. <pub-id pub-id-type="doi">10.7759/cureus.47716</pub-id>.<pub-id pub-id-type="pmid">38022259</pub-id>
</mixed-citation></ref><ref id="bmc70119-bib-0033"><mixed-citation publication-type="journal" id="bmc70119-cit-0033">
<string-name>
<surname>Xue</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>He</surname>
</string-name>, <string-name>
<given-names>H. D.</given-names>
<surname>Li</surname>
</string-name>, et&#x000a0;al. <year>2015</year>. &#x0201c;<article-title>Simultaneous Quantification of 25&#x02010;Hydroxyvitamin D<sub>3</sub> and 24,25&#x02010;Dihydroxyvitamin D<sub>3</sub> in Rats Shows Strong Correlations Between Serum and Brain Tissue Levels</article-title>.&#x0201d; <source>International Journal of Endocrinology</source>
<volume>2015</volume>: <elocation-id>296531</elocation-id>. <pub-id pub-id-type="doi">10.1155/2015/296531</pub-id>.<pub-id pub-id-type="pmid">26713090</pub-id>
</mixed-citation></ref></ref-list></back></article>